Remove Bacterium Remove Development Remove Genetics
article thumbnail

Solving a mystery: How the TB bacterium develops rapid resistance to antibiotics

Scienmag

Credit: SDSU For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.

article thumbnail

Small RNA as a central player in infections

Scienmag

Credit: (Image: Chair of Molecular Infection Biology II / University of Wuerzburg / SCIGRAPHIX) More than half of the world’s population carries the bacterium Helicobacter pylori in their stomach mucosa.

RNA 93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A new era in diagnostics: The growing demand for POC testing

Pharmaceutical Technology

In the pursuit of improving patient care, the continued development of POC testing can help support future demand for rapid diagnosis and treatment, with opportunities to implement successful POC facilities expanding over the years as the technology has improved.

article thumbnail

Cause of 1990s Argentina cholera epidemic uncovered

Scienmag

Work allows genomic monitoring for epidemic strains of Vibrio cholerae bacteria The evolution of epidemic and endemic strains of the cholera-causing bacterium Vibrio cholerae in Argentina has been mapped in detail by researchers at the Wellcome Sanger Institute, the London School of Hygiene and Tropical Medicine, the University of Cambridge and the (..)

article thumbnail

Education and empowerment would provide more equal access to care

pharmaphorum

Ella, 28, was diagnosed with cystic fibrosis – a rare genetic disease which causes a build-up of thick, sticky mucus in the lungs, digestive tract, and sinuses – at 18 months old. Then, in 2018, Ella developed an infection that would not respond to treatment and was told her lung transplant was her only option. I was really sick.

Bacteria 113
article thumbnail

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

XTalks

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The bacterium then secretes pDNA-protein complexes, triggering an immune response to treat and prevent infection associated with the delivered genes.

article thumbnail

In Medieval Times, Plagues ‘Sped Up’ With Each New Outbreak

The Pharma Data

Previous genetic studies identified the pathogen that causes plague, including the Black Death of 1348, which killed more than one-third of Europe’s population, and the Great Plague of 1665. Growth rates for both epidemics are more consistent with bubonic plague, which is transmitted by bites of infected fleas, the researchers said.